Welcome • User Guide
ToS • Privacy • Canary
Donate • Bugs • License

©2024 Poal.co

205

FIRST ON THE DAILY SIGNAL—A team leader at the U.S. Food and Drug Administration recommended approving “puberty blockers” for teens who identify as transgender even while noting that a recent study showed these drugs are associated with an “increased risk in depression and suicidality.”

Many activists claim that children struggling with gender dysphoria (the persistent condition of identifying with the gender opposite their biological sex) must receive experimental drugs to make their bodies resemble bodies of the opposite sex to stop them from committing suicide, yet the FDA study suggested these drugs actually increase the risk of suicide.

In one email on Jan. 25, 2022, Shannon Sullivan, clinical team leader at the FDA’s Division of General Endocrinology, noted that the agency’s Division of Metabolism and Endocrinology Products performed a “safety review of the GnRH agonist class in pediatric patients in 2016/2017.” GnRH stands for “Gonadatropin-releasing hormone,” and GnRH agonists prevent the natural release of testosterone and estrogen that initiate puberty. . .

Archive (archive.today)

>FIRST ON THE DAILY SIGNAL—A team leader at the U.S. Food and Drug Administration recommended approving “puberty blockers” for teens who identify as transgender even while noting that a recent study showed these drugs are associated with an “increased risk in depression and suicidality.” >Many activists claim that children struggling with gender dysphoria (the persistent condition of identifying with the gender opposite their biological sex) must receive experimental drugs to make their bodies resemble bodies of the opposite sex to stop them from committing suicide, yet the FDA study suggested these drugs actually increase the risk of suicide. >In one email on Jan. 25, 2022, Shannon Sullivan, clinical team leader at the FDA’s Division of General Endocrinology, noted that the agency’s Division of Metabolism and Endocrinology Products performed a “safety review of the GnRH agonist class in pediatric patients in 2016/2017.” GnRH stands for “Gonadatropin-releasing hormone,” and GnRH agonists prevent the natural release of testosterone and estrogen that initiate puberty. . . [Archive](https://archive.today/Cgmu0)

(post is archived)

You are currently inside a comment thread.
Click here to see all the comments (1).
[–] • 2 pts

WE must stop playing their insane game and force the Fact that there are only Two sexes and it is Impossible for one to 'Become' the other. The ONLY 'transgenders' are Born with parts of both sexes and one is dominate and operational.